RP Bio Inc. (KOSDAQ:314140)
6,410.00
+10.00 (0.16%)
At close: Mar 27, 2026
10.71% (1Y)
| Market Cap | 55.55B +21.4% |
| Revenue (ttm) | 134.21B +4.7% |
| Net Income | 4.89B |
| EPS | 564.30 |
| Shares Out | 8.67M |
| PE Ratio | 11.36 |
| Forward PE | n/a |
| Dividend | 50.00 (0.78%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 4,940 |
| Average Volume | 21,582 |
| Open | 6,380.00 |
| Previous Close | 6,400.00 |
| Day's Range | 6,200.00 - 6,420.00 |
| 52-Week Range | 4,765.00 - 9,130.00 |
| Beta | 0.55 |
| RSI | 44.64 |
| Earnings Date | n/a |